登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C54H92NO8P
化学文摘社编号:
分子量:
914.28
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
产品名称
23:2 二炔基PC [DC(8,9)PC], Avanti Research™ - A Croda Brand 870016P, powder
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 g (870016P-1g), pkg of 1 × 200 mg (870016P-200mg), pkg of 1 × 25 mg (870016P-25mg), pkg of 1 × 500 mg (870016P-500mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 870016P
shipped in
dry ice
storage temp.
−20°C
SMILES string
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCC#CC#CCCCCCCCCCC)=O)COC(CCCCCCCCC#CC#CCCCCCCCCCC)=O)=O
InChI
1S/C54H92NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-42-44-46-53(56)60-50-52(51-62-64(58,59)61-49-48-55(3,4)5)63-54(57)47-45-43-41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h52H,6-23,32-51H2,1-5H3/t52-/m1/s1
InChI key
IDBJTPGHAMAEMV-OIVUAWODSA-N
General description
23:2 二炔PC [DC(8,9)PC]是手性二炔磷脂酰胆碱（PC）。
Application
23:2 二炔PC [DC(8,9)PC]已用于制造聚二乙炔囊泡。它也已用于制备脂质组织纤溶酶原激活剂（脂质-tPA）混悬液。
Packaging
20 mL棕色玻璃螺旋盖小瓶（870016P-1g）
20 mL棕色玻璃螺旋盖小瓶（870016P-500mg）
5 mL棕色玻璃螺旋盖小瓶（870016P-200mg）
5 mL棕色玻璃螺旋盖小瓶（870016P-25mg）
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
D S Johnston et al.
Biochimica et biophysica acta, 602(1), 57-69 (1980-10-16)
A new approach has been developed for the study of model and natural biomembranes. This involves the cross-linking of diacetylene groups after ultraviolet irradiation. For the study of model biomembranes, pure phospholipids (phosphatidylcholines) have been synthesized containing diacetylene groups in
Amichai Yavlovich et al.
Journal of thermal analysis and calorimetry, 98(1), 97-104 (2010-02-18)
We describe a novel class of light-triggerable liposomes prepared from a photo-polymerizable phospholipid DC(8,9)PC (1,2- bis (tricosa-10,12-diynoyl)-sn-glycero-3-phosphocholine) and DPPC (1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine). Exposure to UV (254 nm) radiation for 0-45 minutes at 25 degrees C resulted in photo-polymerization of DC(8,9)PC in these
J A Hayward et al.
Biomaterials, 5(3), 135-142 (1984-05-01)
A major restriction in the application of polymeric biomaterials is the propensity of their surfaces to support thrombosis. Theoretical approaches to the design of thromboresistant polymers have been inadequate because of the complexity of surface thrombosis. We have developed a
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 870016P-1G | 04061835184477 |
| 870016P-200MG | 04061835184484 |
| 870016P-25MG | 04061835184491 |
| 870016P-500MG | 04061835184507 |